Tag: Caire

 The respiratory market has undergone a series of shifts over the past two-and-a-half years, due to the pandemic and other issues, like supply chain disruptions. But now it appears that external forces have waned, creating a more stable environment for providers, respiratory manufacturers say.  Jim Worrell, chief commercial officer for Pinellas Park, Fla.-based Quality Biomedical, called the past couple of years “a roller coaster ride” as the industry continues to emerge...

BALL GROUND, Ga. – CAIRE on Jan. 4 finalized its acquisition of MGC Diagnostics Holdings, positioning itself to cover another step in the “patient journey,” said Earl Lawson, president and CEO.  MGC is a manufacturer of non-invasive cardiorespiratory diagnostic systems like pulmonary function testing systems and spirometers.  “It really improves the way we’re supporting the patient,” Lawson said. “We were looking for an opportunity that was...

BALL GROUND, Ga. - CAIRE has finalized the acquisition of St. Paul, Minn.-based MGC Diagnostics Holdings, Inc. (MGC), a maker of non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease. “This acquisition provides the means of serving the patient in a more holistic way — improving their quality of care throughout their entire journey,” said Earl Lawson, CAIRE president and CEO. “With...

WASHINGTON – CMS on Dec. 2 announced a 9.1% increase for competitively bid DMEPOS items in non-competitive bidding areas and a 6.4% increase for bid items in former CBAs for calendar year 2023, AAHomecare reports.  Non-bid items will receive an 8.7% increase.  Typically, the CPI-U increases for DME have been 1%-3%. Last year, the inflation adjustment was 5% in former CBAs and 5.4% non-CBAs.  “These increases will help DME suppliers who have been dealing with rising...

BALL GROUND, Ga. – CAIRE, a subsidiary of NGK Spark Plug, has announced its plans to acquire St. Paul, Minn.-based MGC Diagnostics Holdings. MGC designs, develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease. “CAIRE is firmly committed to driving future growth by expanding our offerings in the clinical setting to better serve those individuals...

BALL GROUND, Ga. – CAIRE has tapped Strongsville, Ohio-based Repair Authority, an HME repair company, to become part of the company’s Authorized Service Center network. Through this new agreement, Repair Authority will be able to support CAIRE customers with in-warranty repairs, which is critical support needed by some of the largest HME providers. “We’re honored to have been selected by CAIRE as an authorized service provider for its stationary and portable oxygen concentrator...

ELYRIA, Ohio – Invacare is streamlining its operations in the United States, primarily related to headcount reductions, to improve its cost structure, according to a May 4 filing with the U.S. Securities and Exchange Commission.  As a result, the company anticipates annual pre-tax savings of about $2.8 million, with about $1.9 million to be realized in 2022. It will incur restructuring charges of $800,000 and expects to make cash payments in the same amount, primarily related to...

BALL GROUND, Ga. – CAIRE expects to make its Companion 5 and NewLife Intensity 10 stationary oxygen concentrators available in Latin America in July, following anticipated approval by the Brazilian Health Regularity Agency (Anvisa). “During the past two years, the COVID-19 pandemic oxygen shortages throughout South America have underscored the need to expand CAIRE’s portfolio of equipment available to providers to serve patients prescribed oxygen as they are discharged from the...

BALL GROUND, Ga. – CAIRE is celebrating the 20th anniversary of the launch of the first portable oxygen concentrator, the LifeStyle. “For us, pioneering the first portable oxygen concentrator has been both a point of pride, and an ongoing incentive to continue to innovate and develop those technologies that will ensure clinically efficacious oxygen delivery and an improve quality of life for all of our users around the world,” said Earl Lawson, CEO of CAIRE. Introduced under CAIRE’s...

BALL GROUND, Ga. – CAIRE’s FreeStyle Comfort portable oxygen concentrator outperformed other market leading devices in a recent study designed to assess the effectiveness of these devices in delivering oxygen to patients. “Portable oxygen concentrators are intended to allow patients to maintain a more active lifestyle despite the constraints which COPD or other respiratory conditions might introduce,” said Barry hassett, vice president of global marketing. “The FreeStyle...